| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ADCY2 | CNR1 | ENSCSAP00000013370 | ENSCSAP00000017801 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.909 |
| ADCY2 | ENTPD2 | ENSCSAP00000013370 | ENSCSAP00000012503 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Ectonucleoside triphosphate diphosphohydrolase 2; Belongs to the GDA1/CD39 NTPase family. | 0.905 |
| ADCY2 | GNAL | ENSCSAP00000013370 | ENSCSAP00000013557 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | G protein subunit alpha L. | 0.904 |
| ADCY2 | GNAO1 | ENSCSAP00000013370 | ENSCSAP00000001466 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | G protein subunit alpha o1. | 0.945 |
| ADCY2 | GNAS | ENSCSAP00000013370 | ENSCSAP00000011662 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Uncharacterized protein. | 0.972 |
| ADCY2 | PRKACB | ENSCSAP00000013370 | ENSCSAP00000016607 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Protein kinase cAMP-activated catalytic subunit beta; Belongs to the protein kinase superfamily. | 0.926 |
| ADCY2 | PRKACG | ENSCSAP00000013370 | ENSCSAP00000018038 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Protein kinase cAMP-activated catalytic subunit gamma; Belongs to the protein kinase superfamily. | 0.923 |
| ADCY2 | PRKCD | ENSCSAP00000013370 | ENSCSAP00000009231 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Protein kinase C delta type; Calcium-independent, phospholipid- and diacylglycerol (DAG)- dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti- apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression; Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily. | 0.905 |
| ADCY2 | RAPGEF3 | ENSCSAP00000013370 | ENSCSAP00000002884 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Rap guanine nucleotide exchange factor 3. | 0.916 |
| ADCY2 | RAPGEF4 | ENSCSAP00000013370 | ENSCSAP00000010836 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | Rap guanine nucleotide exchange factor 4. | 0.921 |
| CNR1 | ADCY2 | ENSCSAP00000017801 | ENSCSAP00000013370 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | 0.909 |
| CNR1 | GNAO1 | ENSCSAP00000017801 | ENSCSAP00000001466 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha o1. | 0.937 |
| CNR1 | GNAS | ENSCSAP00000017801 | ENSCSAP00000011662 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Uncharacterized protein. | 0.415 |
| ENTPD2 | ADCY2 | ENSCSAP00000012503 | ENSCSAP00000013370 | Ectonucleoside triphosphate diphosphohydrolase 2; Belongs to the GDA1/CD39 NTPase family. | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | 0.905 |
| GNAL | ADCY2 | ENSCSAP00000013557 | ENSCSAP00000013370 | G protein subunit alpha L. | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | 0.904 |
| GNAL | GNAS | ENSCSAP00000013557 | ENSCSAP00000011662 | G protein subunit alpha L. | Uncharacterized protein. | 0.946 |
| GNAO1 | ADCY2 | ENSCSAP00000001466 | ENSCSAP00000013370 | G protein subunit alpha o1. | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. | 0.945 |
| GNAO1 | CNR1 | ENSCSAP00000001466 | ENSCSAP00000017801 | G protein subunit alpha o1. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.937 |
| GNAO1 | GNAS | ENSCSAP00000001466 | ENSCSAP00000011662 | G protein subunit alpha o1. | Uncharacterized protein. | 0.412 |
| GNAO1 | PRKACB | ENSCSAP00000001466 | ENSCSAP00000016607 | G protein subunit alpha o1. | Protein kinase cAMP-activated catalytic subunit beta; Belongs to the protein kinase superfamily. | 0.703 |